Related Experiment Video
Updated: Apr 7, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Writing Effective Insurance Justification Letters for Cancer Genetic Testing: A Streamlined Approach
1Yale Cancer Center/Yale University School of Medicine, New Haven, Connecticut.
Navigating insurance coverage for cancer genetic testing can be challenging. This paper offers practical guidance and successful strategies for writing justification letters to improve insurance approval for cancer predisposition testing.
Area of Science:
- Medical Genetics
- Health Services Research
Background:
- Discussions within the National Society of Genetic Counselors Cancer Special Interest Group (NSGC Cancer-SIG) highlight challenges in obtaining insurance coverage for cancer genetic testing.
- Genetic counselors frequently encounter difficulties securing insurance approval for patients requiring cancer predisposition testing.
Purpose of the Study:
- To provide practical guidance on writing effective justification letters for insurance coverage of cancer genetic testing.
- To share successful insurance approval strategies and case examples for cancer genetic testing.
Main Methods:
- Analysis of discussions from the NSGC Cancer-SIG listserv.
- Compilation of best practices and successful strategies for insurance appeals.
- Inclusion of anonymized examples of successful justification letters.
Main Results:
- Identification of common barriers to insurance coverage for genetic testing.
- Development of a framework for constructing persuasive justification letters.
- Demonstration of successful outcomes through strategic letter writing and appeals.
Conclusions:
- Effective justification letters are crucial for securing insurance coverage for cancer genetic testing.
- Sharing successful strategies can empower genetic counselors and improve patient access to necessary testing.
- Further resources and standardized approaches may enhance insurance approval rates for hereditary cancer testing.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer Survival Analysis
Cancer

